Home › Keelholtekanker › Illinois › Chicago
Keelholtekanker klinische studies in Chicago, IL
8 studies voor Keelholtekanker zoeken deelnemers op locaties in en rond Chicago (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RekruterenFase 2
- Rush MD Anderson Cancer Center, Chicago
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruterenFase 3
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruterenFase 2
- Northwestern University, Chicago
- University of Illinois, Chicago
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruterenFase 1
- Northwestern University, Chicago
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruterenFase 2
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruterenFase 2
- Northwestern University, Chicago
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruterenFase 3
- Northwestern University, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chicago
Keelholtekanker studies in andere steden
- Atlanta, GA8 studies
- Milwaukee, WI8 studies
- Kansas City, MO7 studies
- Portland, OR7 studies
- St. Louis, MO7 studies
- Baltimore, MD6 studies
- Cincinnati, OH6 studies
- Edison, NJ6 studies
- Richmond, VA6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
- Overland Park, KS5 studies
Andere studies in Chicago
- Niet-kleincellige longkanker61 studies
- Borstkanker59 studies
- Kanker (alle vormen)51 studies
- Metastatische kanker45 studies
- Prostaatkanker45 studies
- Longkanker41 studies
- Obesitas41 studies
- Eierstokkanker36 studies
- Colorectale kanker34 studies
- Beroerte34 studies
- Hartfalen31 studies
- Overgewicht29 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.